We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

980 hedge funds and large institutions have $45.1B invested in Celgene Corp in 2014 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 345 increasing their positions, 432 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more first-time investments, than exits

New positions opened: 95 | Existing positions closed: 87

0% less funds holding

Funds holding: 983980 (-3)

20% less repeat investments, than reductions

Existing positions increased: 345 | Existing positions reduced: 432

20% less capital invested

Capital invested by funds: $56.6B → $45.1B (-$11.5B)

30% less call options, than puts

Call options by funds: $696M | Put options by funds: $998M

51% less funds holding in top 10

Funds holding in top 10: 8743 (-44)

Holders
980
Holders Change
-3
Holders Change %
-0.31%
% of All Funds
28.31%
Holding in Top 10
43
Holding in Top 10 Change
-44
Holding in Top 10 Change %
-50.57%
% of All Funds
1.24%
New
95
Increased
345
Reduced
432
Closed
87
Calls
$696M
Puts
$998M
Net Calls
-$302M
Net Calls Change
-$88.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Norges Bank
26
Norges Bank
Norway
$412M
DCP
27
DSM Capital Partners
Florida
$364M +$27M +341,016 +7%
MAA
28
Managed Account Advisors
New Jersey
$356M -$18.1M -228,588 -4%
AllianceBernstein
29
AllianceBernstein
Tennessee
$336M -$154M -1,940,714 -29%
UBS AM
30
UBS AM
Illinois
$332M +$32.6M +412,166 +9%
GVI
31
Green Valley Investors
Delaware
$321M
BB
32
BB Biotech
Switzerland
$305M +$24.6M +310,756 +8%
Westfield Capital Management
33
Westfield Capital Management
Massachusetts
$300M -$6.97M -87,956 -2%
MCM
34
Marsico Capital Management
Colorado
$294M -$73.8M -931,546 -18%
Swedbank
35
Swedbank
Sweden
$289M +$398M +5,020,908 New
Goldman Sachs
36
Goldman Sachs
New York
$282M -$12.9M -163,374 -4%
Morgan Stanley
37
Morgan Stanley
New York
$272M -$55.2M -696,556 -15%
American Century Companies
38
American Century Companies
Missouri
$255M -$11.2M -141,208 -4%
PI
39
Putnam Investments
Massachusetts
$251M -$8.66M -109,362 -3%
Legal & General Group
40
Legal & General Group
United Kingdom
$238M -$8.57M -108,274 -3%
Renaissance Technologies
41
Renaissance Technologies
New York
$224M +$31.9M +402,722 +14%
AAMU
42
Amundi Asset Management US
Massachusetts
$217M +$2.31M +29,200 +0.9%
BA
43
BlackRock Advisors
Delaware
$215M -$118M -1,489,774 -33%
TG
44
TCW Group
California
$206M +$13M +164,180 +6%
CS
45
Credit Suisse
Switzerland
$204M -$18.2M -230,058 -7%
U
46
UBS
Switzerland
$204M +$12.6M +159,636 +6%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$201M +$97.2M +1,227,782 +75%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$200M +$17.3M +218,700 +8%
AL
49
AJO LP
Pennsylvania
$199M -$4.49M -56,700 -2%
Prudential Financial
50
Prudential Financial
New Jersey
$198M +$74.3M +937,660 +50%

CELG Hedge Fund Activity: Q1 2014 in Review

980 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q1 2014, worth a combined $45.1B — down 20% from $56.6B a quarter earlier.

Buyers outnumbered sellers: 95 funds opened new CELG positions and 87 closed out — a net gain of 8 holders — while 345 added to existing stakes and 432 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $126M. The largest seller was Fidelity Investments, cutting an estimated $473M.

  • 980 institutional investors held Celgene Corp (CELG) as of Q1 2014, down from 983 in Q4 2013.
  • Funds reported $45.1B of Celgene Corp stock for Q1 2014, down 20% quarter-over-quarter.
  • 95 funds opened new Celgene Corp positions in Q1 2014 and 87 closed out, a net change of +8 holders.
  • The largest Celgene Corp buyer in Q1 2014 was BlackRock Fund Advisors, an estimated $126M added.
  • The largest Celgene Corp seller in Q1 2014 was Fidelity Investments, an estimated $473M sold.

Based on aggregated 13F filings for Q1 2014.